Invokana Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Impact of a Short-term Treatment With Canagliflozin (Canacardia-HF)
Conditions:   Type2 Diabetes;   Heart Failure Interventions:   Drug: Canagliflozin 100mg;   Drug: Placebo oral capsule;   Radiation: PET imaging Sponsors:   Université de Sherbrooke;   Janssen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2017 Category: Research Source Type: clinical trials